ambrisentan mylan
mylan s.a.s - ambrisentan - hypertension, lunge - antihypertensiva, - ambrisentan mylan er indiceret til behandling af pulmonal arteriel hypertension (pah) hos voksne patienter, som funktionel class (fc) ii til iii, herunder til brug i kombination behandling. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah associeret med bindevævssygdom. ambrisentan mylan er indiceret til behandling af pulmonal arteriel hypertension (pah) hos voksne patienter, som funktionel class (fc) ii til iii, herunder til brug i kombination behandling. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah associeret med bindevævssygdom.
ambrisentan "accord" 5 mg filmovertrukne tabletter
accord healthcare b.v. - ambrisentan - filmovertrukne tabletter - 5 mg
ambrisentan "aop" 5 mg filmovertrukne tabletter
aop orphan pharmaceuticals gmbh - ambrisentan - filmovertrukne tabletter - 5 mg
ambrisentan "teva" 5 mg filmovertrukne tabletter
teva b.v. - ambrisentan - filmovertrukne tabletter - 5 mg
ambrisentan "sandoz" 5 mg filmovertrukne tabletter
sandoz a/s - ambrisentan - filmovertrukne tabletter - 5 mg
ambrisentan "accord" 10 mg filmovertrukne tabletter
accord healthcare b.v. - ambrisentan - filmovertrukne tabletter - 10 mg
selenoprecise 100 mikrogram depottabletter
pharma nord aps - selenoprecise yeast - depottabletter - 100 mikrogram
ambrisentan "teva" 10 mg filmovertrukne tabletter
teva b.v. - ambrisentan - filmovertrukne tabletter - 10 mg
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kylling - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenzavirusoverfladeantigener (hæmagglutinin og neuraminidase) af stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.